Latest News and Press Releases

AnswersNow named 2025 Best Telehealth Platform by MedTech Breakthrough

Yamo Pharma's Phase 2 data at INSAR 2025 show L1-79 delivers statistically significant and clinically meaningful improvements in core autism symptoms.

Washington, DC, April 18, 2025 (GLOBE NEWSWIRE) -- ThinkCareBelieve's Week 13 Article: https://thinkcarebelieve.blog/2025/04/18/week-13-under-president-trumps-leadership/ Article on Release of...

Thought Leadership & Innovation Foundation Awareness Month Published on SHSMD Observance Calendar

Las Vegas, NV, March 24, 2025 (GLOBE NEWSWIRE) -- PatchMD, a leader in innovative nutrient delivery systems, proudly announces the launch of its new Mito Cocktail Patch, designed to support...

ROCKVILLE, MD, March 18, 2025 (GLOBE NEWSWIRE) -- This April, the Autism Society of America celebrates Autism Acceptance Month alongside its 60th anniversary by fostering meaningful connections,...

Little Leaves Behavioral Services expands in Maryland and Virginia. Four new ABA therapy centers will open this summer for young children with autism.

Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.

Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.

Spike protein produced by the Covid mRNA vaccines penetrates the brain, and the fetal brain, causing long-term possibly catastrophic effects